Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid Metabolism (LIPOTAR-07)
Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid Metabolism in ARV-naive HIV-infected Subjects
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
A PHASE4 clinical study on HIV Infections, this trial is ongoing. The trial is conducted by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau and has accumulated 6 data snapshots since 2008. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE4
First recorded
Sep 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Germans Trias i Pujol Hospital
- Hospital Universitari Joan XXIII de Tarragona.
- Hospitales Universitarios Virgen del Rocío
- Juan A. Arnaiz
For direct contact, visit the study record on ClinicalTrials.gov .